Home / Companies / Saranas

Texas Health Atlas · Houston

Saranas

Makes the Early Bird Bleed Monitoring System, which uses bioimpedance sensors to detect internal bleeding during endovascular procedures.

Location
Houston, Texas
Focus
MedTech
Stage / status
FDA De Novo (2019)
Notes
FDA granted De Novo classification in 2019.
Website
saranas.com
Last reviewed
Sep 29, 2026

Coverage

Future Health ExplainedCleared, approved, De Novo, Breakthrough: how FDA medical device pathways workWhat "FDA-cleared", "FDA-approved", De Novo, IDE and Breakthrough designation actually mean, with examples from Texas medtech companies.Sep 29, 2026

Sources

  1. www.businesswire.com/news/home/20190305005123/en/FDA-Grants-Saranas-De-Novo-Designation-Early
  2. saranas.com/product/

Regulatory status is as stated by the company or its public filings on the review date; it changes. Work here? Send a correction or update.